These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1376 related items for PubMed ID: 8095026
1. Effect of deoxycytidine on 2-chloro-deoxyadenosine-mediated growth inhibition of normal human erythroid and myeloid progenitor cells. Bilgeri R, Petzer AL, Zilian U, Geisen FH, Schirmer M, Haun M, Konwalinka G. Exp Hematol; 1993 Mar; 21(3):432-7. PubMed ID: 8095026 [Abstract] [Full Text] [Related]
2. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia. Wisniewski D, Strife A, Atzpodien J, Clarkson BD. Cancer Res; 1987 Sep 15; 47(18):4788-94. PubMed ID: 3040231 [Abstract] [Full Text] [Related]
3. The effects of transforming growth factor beta 3 on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral blood. Strife A, Lambek C, Perez A, Darzynkiewicz Z, Skierski J, Gulati S, Haley JD, ten Dijke P, Iwata KK, Clarkson BD. Cancer Res; 1991 Sep 15; 51(18):4828-36. PubMed ID: 1893375 [Abstract] [Full Text] [Related]
4. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation. Carlo-Stella C, Mangoni L, Almici C, Garau D, Craviotto L, Piovani G, Caramatti C, Rizzoli V. Exp Hematol; 1992 Mar 15; 20(3):328-33. PubMed ID: 1568448 [Abstract] [Full Text] [Related]
5. In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide. Ratajczak MZ, Ratajczak J, Kuczynski W, Light B, Lusk EJ, Gewirtz AM. Exp Hematol; 1993 Dec 15; 21(13):1663-7. PubMed ID: 8243568 [Abstract] [Full Text] [Related]
6. Inhibition of human bone marrow-derived stem cell colony formation (CFU-E, BFU-E, and CFU-GM) following in vitro exposure to organophosphates. Gallicchio VS, Casale GP, Watts T. Exp Hematol; 1987 Dec 15; 15(11):1099-102. PubMed ID: 3678410 [Abstract] [Full Text] [Related]
7. Growth-inhibitory effect of 2-CdA on myeloid CFU-GM progenitors in normal human long-term bone marrow cultures and its compensation by G-CSF or IL-3. Petzer AL, Geisen FH, Bilgeri R, Zilian U, Haun M, Herold M, Braunsteiner H, Konwalinka G. Exp Hematol; 1995 Jun 15; 23(6):529-34. PubMed ID: 7539380 [Abstract] [Full Text] [Related]
8. Effects of erythroid differentiation factor (EDF) on proliferation and differentiation of human hematopoietic progenitors. Nakao K, Kosaka M, Saito S. Exp Hematol; 1991 Dec 15; 19(11):1090-5. PubMed ID: 1752318 [Abstract] [Full Text] [Related]
9. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells. Broxmeyer HE, Lu L, Platzer E, Feit C, Juliano L, Rubin BY. J Immunol; 1983 Sep 15; 131(3):1300-5. PubMed ID: 6193183 [Abstract] [Full Text] [Related]
10. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation. Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S. Exp Hematol; 1995 Dec 15; 23(14):1520-6. PubMed ID: 8542941 [Abstract] [Full Text] [Related]
11. Inhibition of human bone marrow progenitors by the synthetic tetrapeptide AcSDKP. Guigon M, Bonnet D, Lemoine F, Kobari L, Parmentier C, Mary JY, Najman A. Exp Hematol; 1990 Nov 15; 18(10):1112-5. PubMed ID: 2209766 [Abstract] [Full Text] [Related]
12. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma. Broxmeyer HE, Benninger L, Cooper S, Hague N, Benjamin RS, Vadhan-Raj S. Exp Hematol; 1995 Apr 15; 23(4):335-40. PubMed ID: 7895781 [Abstract] [Full Text] [Related]
13. Thy-1 is a differentiation antigen that characterizes immature murine erythroid and myeloid hematopoietic progenitors. Miller BA, Lipton JM, Linch DC, Burakoff SJ, Nathan DG. J Cell Physiol; 1985 Apr 15; 123(1):25-32. PubMed ID: 2857726 [Abstract] [Full Text] [Related]
14. Prevention of hematopoietic myeloid and megakaryocyte toxicity associated with zidovudine in vivo in mice with recombinant GM-CSF. Gallicchio VS, Hughes NK, Tse KF. Growth Regul; 1994 Jun 15; 4(2):41-7. PubMed ID: 7950902 [Abstract] [Full Text] [Related]
16. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma. Broxmeyer HE, Williams DE, Lu L, Cooper S, Anderson SL, Beyer GS, Hoffman R, Rubin BY. J Immunol; 1986 Jun 15; 136(12):4487-95. PubMed ID: 3086433 [Abstract] [Full Text] [Related]
17. Action of antithymocyte globulin on normal human erythroid progenitor cell proliferation in vitro: erythropoietic growth-enhancing factors are released from marrow accessory cells. Mangan KF, D'Alessandro L, Mullaney MT. J Lab Clin Med; 1986 Apr 15; 107(4):353-64. PubMed ID: 2420910 [Abstract] [Full Text] [Related]
19. Acute toxic effects of 3'-azido-3'-deoxythymidine (AZT) on normal and regenerating murine hematopoiesis. Scheding S, Media JE, Nakeff A. Exp Hematol; 1994 Jan 15; 22(1):60-5. PubMed ID: 8282060 [Abstract] [Full Text] [Related]